defining high-risk cll: known and emerging mutations
Published 1 year ago • 535 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
2:54
the definition of high-risk cll
-
2:08
defining high-risk disease in cll
-
2:36
treatment approaches to cll with high-risk molecular features
-
1:09
current and emerging treatment strategies for cll & defining the optimal treatment duration
-
1:48
patient risk stratification in cll and selection of treatment approaches
-
1:15
exciting updates in cll and the importance of immune characterization
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
3:57
what is chronic lymphocytic leukaemia?
-
4:19
cll: what is 'watch & wait' and what can a patient do during this phase?
-
1:36
selecting the best treatment option in cll
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
0:56
the current treatment landscape in cll
-
6:19
machine learning to identify cll patients at high risk of infection
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
2:08
an insight into the current understanding of risk factors for cll
-
34:10
chronic lymphocytic leukemia (cll)
-
1:29
the importance of treatment sequencing in cll
-
1:11
genomic testing can help identify patient risk factors and guide clinical decision-making
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:41
btk and plcg2 mutations in cll patients taking ibrutinib
-
1:39
the importance of diagnostic testing in cll
-
3:27
phenotypes and molecular markers indicating elevated risk of rt in patients with cll